Focusing on Emotions for People Living with Obesity: Implications for Mental and Physical Health
Participants in obesity management programs experience weight loss and improvements in anxiety, depression, and blood pressure, highlighting the importance of addressing emotional well-being alongside physical health outcomes in individuals living with obesity.
January 2022
Nitazoxanide for COVID-19 Treatment: Regulatory Status Update
Emergency use authorization for nitazoxanide as a potential treatment for COVID-19 is requested from the FDA in the US, signaling ongoing efforts to repurpose existing drugs for combating the pandemic and expanding therapeutic options for affected individuals.
January 2022
Obesity and Long-Term Complications of COVID-19: Implications for Disease Management and Public Health Strategies
Patients with obesity have a 30% higher risk of hospital admission for long-term complications of COVID-19, highlighting the need for targeted interventions and public health initiatives to mitigate disparities and improve outcomes in vulnerable populations.
December 2021
FDA and CDC Pause Use of Johnson & Johnson Vaccine: Safety Concerns
Following reports of rare blood clotting events, the FDA and CDC recommend a pause in the use of the Johnson & Johnson vaccine, highlighting the importance of post-authorization safety monitoring and rapid response to vaccine-related adverse events.
December 2021
Obesity and Hyperinsulinemia: Pathophysiological Interplay and Clinical Implications
The adverse consequences attributed to obesity may be mediated by hyperinsulinemia, suggesting a complex interplay between metabolic and hormonal factors in obesity-related complications and underscoring the importance of targeted interventions in managing obesity-related health risks.
November 2021
Exercise-Induced Weight Loss: Mechanisms and Strategies
Physical activity may prompt increased food intake, posing challenges to weight loss efforts, understanding underlying mechanisms and implementing strategies to mitigate compensatory eating behaviors are crucial for achieving sustainable weight management goals.
November 2021
Overweight and Obesity in COVID-19: Impact on Disease Severity
Higher body mass index shows a dose-response relationship with severe COVID-19 outcomes, underscoring the importance of obesity management and weight loss interventions in reducing disease severity and mitigating healthcare resource utilization in the pandemic.
October 2021
